MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 138 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 2.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,067,000 | -21.7% | 860,224 | +94.5% | 0.00% | 0.0% |
| Q1 2017 | $1,363,000 | +168.8% | 442,304 | +255.6% | 0.00% | +100.0% |
| Q4 2016 | $507,000 | -95.9% | 124,378 | -93.6% | 0.00% | -95.2% |
| Q3 2016 | $12,384,000 | +12.3% | 1,950,306 | -4.7% | 0.02% | -16.0% |
| Q2 2016 | $11,031,000 | -1.5% | 2,046,523 | +44.4% | 0.02% | +4.2% |
| Q4 2015 | $11,197,000 | +248.9% | 1,417,296 | +446.1% | 0.02% | +300.0% |
| Q2 2015 | $3,209,000 | -69.7% | 259,507 | -70.9% | 0.01% | -70.0% |
| Q1 2015 | $10,603,000 | -47.8% | 892,508 | -50.4% | 0.02% | -53.5% |
| Q4 2014 | $20,316,000 | +16.2% | 1,797,848 | -9.7% | 0.04% | -2.3% |
| Q3 2014 | $17,483,000 | +16.7% | 1,991,222 | -3.1% | 0.04% | +4.8% |
| Q2 2014 | $14,985,000 | +865.5% | 2,055,592 | +567.6% | 0.04% | +950.0% |
| Q1 2014 | $1,552,000 | +48.8% | 307,886 | +57.4% | 0.00% | +33.3% |
| Q4 2013 | $1,043,000 | +44.9% | 195,646 | +3.0% | 0.00% | +50.0% |
| Q3 2013 | $720,000 | +373.7% | 189,900 | +740.3% | 0.00% | – |
| Q2 2013 | $152,000 | – | 22,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|